Tagged with GI

Puerto Rico José F. Oramas, Caribbean GEO Country Manager for UPS, highlights the company’s strategic role in Puerto Rico and the Caribbean, particularly within the life sciences and logistics sectors. With nearly four decades of experience at UPS, Oramas shares his perspectives on navigating challenges, leveraging Puerto Rico’s unique geographic and economic…

Puerto Rico Puerto Rico leads all US jurisdictions in biopharmaceutical exports, shipping to over 120 countries. With a rapidly expanding life sciences sector and growing pharma logistics capabilities, the island is positioning itself as a global hub—but industry leaders say there’s still work to be done.   Life Sciences and Logistics Dynamo…

Saudi Arabia Extending not only lifespan, but “healthspan,” and ensuring people live healthier lives for longer is moving beyond purely clinical settings. Experts gathered last week at the Global Healthspan 2025 Summit in Riyadh, Saudi Arabia focused on factors such as lifestyle, the role of virtual tools, and a more holistic approach…

Saudi Arabia Dr Vineta Bhalla, Partner and Chief Medical Officer at Deloitte Middle East, brings a wealth of experience from her background as a clinician, public health expert, and healthcare leader in both Singapore and the UK. Bhalla shares her insights into Saudi Arabia’s healthcare transformation, highlighting the Kingdom’s methodical approach to…

APAC Dengue fever is highly endemic in almost every country in Southeast Asia, meaning that Takeda – having launched its dengue vaccine in 2023 – stands to have a massive impact on health in the region. In conversation, Takeda’s Area Head for India and Southeast Asia Dion Warren outlines how Takeda’s…

Saudi Arabia Lyes Salah, General Manager of Amgen Saudi Arabia, delves into the company’s commitment to supporting Saudi Vision 2030 through innovation, strategic partnerships, and talent development. By advancing healthcare accessibility, fostering diversity, and driving digital transformation, Amgen plays a pivotal role in the Kingdom’s healthcare transformation.   Success is not an…

Puerto Rico Tom Vincent, Vice President of Prime Air Cargo, shares insights into the company’s journey as a global logistics leader headquartered in Puerto Rico, the challenges and opportunities in serving the life sciences sector, and the strategic innovations driving its success. Vincent discusses how Prime Air Cargo has adapted to evolving…

Puerto Rico Sascha Herzig, President and CEO of E.T.H. Cargo, provides valuable insights into the company’s journey over the past five years and its key developments since COVID-19. He discusses the evolving logistics landscape in Puerto Rico, highlighting the critical role of the island as a hub for life sciences and the…

Puerto Rico Antonio Medina, CEO of Convergent Strategies, shares insights into Puerto Rico’s evolving economic landscape and the critical role his consultancy plays in driving growth and innovation across industries. He reflects on his experience guiding the island out of bankruptcy as a member of the Financial Oversight Board and discusses key…

Saudi Arabia Mohamed Al Holibi, Regional Business Lead for Health Information Systems at Solventum, shares insights into the evolving role of healthcare data and digital transformation in Saudi Arabia. In this interview, he discusses Solventum’s commitment to supporting Vision 2030 through advanced AI-driven technologies, the implementation of Diagnosis-Related Groups (DRG) systems, and…

Puerto Rico Gustavo A. Hermida, President of CIC Construction Group, shares the remarkable journey of Puerto Rico’s leading general contractor. Built on a foundation of excellence in the pharmaceutical sector, CIC has successfully diversified into healthcare, hospitality, and housing while upholding its rigorous standards of safety, quality, and timely delivery. Hermida highlights…

Germany A roundup of the biggest stories coming out of Germany’s pharma industry, including Bayer’s biggest share price drop in 20 years; Fresenius Kabi’s biosimilar deal with SamChunDang Pharm; Halozyme Therapeutics’ withdrawal from purchase of Evotec; Merck KGaA-controlled MilliporeSigma’s acquisition of HUB Organoids, and Gilead’s USD 465 million solid tumour deal…